Shionogi And UK Universities To Collaborate On New Drug R&D
This article was originally published in PharmAsia News
Executive SummaryOsaka-based Shionogi signed memorandum of understanding Oct. 9 with several UK schools to collaborate on new drug research and development, including Oxford University and King's College London
You may also be interested in...
The latest drug development news and highlights from the Pink Sheet’s US FDA Performance Tracker.
US FDA’s latest effort to provide guidance for consumers on pharmacogenomics tests underscores the challenges the agency faces in the absence of a clear regulatory framework for lab-developed tests – and with no easy mechanism to update labels for off-patent drugs.